A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia

Stephen Couban

科研成果: 期刊稿件 › 文章 › 同行评审

4 引用 （Scopus）

指纹

探究 'A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia' 的科研主题。它们共同构成独一无二的指纹。

Nursing and Health Professions

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science